海特生物(300683)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300683 海特生物

已收盘 07-25 15:00:00

{"stockData":{"symbol":"300683","market":"SZ","secType":"STK","nameCN":"海特生物","latestPrice":46.43,"timestamp":1753427025000,"preClose":42.6,"halted":0,"volume":19995650,"delay":0,"changeRate":0.0899,"floatShares":122000000,"shares":131000000,"eps":-0.5099,"marketStatus":"已收盘","change":3.83,"latestTime":"07-25 15:00:00","open":42.68,"high":47.88,"low":42.05,"amount":894000000,"amplitude":0.1369,"askPrice":46.43,"askSize":376,"bidPrice":46.42,"bidSize":5,"shortable":0,"etf":0,"ttmEps":-0.5099,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"adjPreClose":42.6,"symbolType":"stock","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":46.86,"lowLimit":38.34,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":130894391,"isCdr":false,"pbRate":2.35,"roa":"--","roe":"--","epsLYR":-0.53,"committee":-0.896985,"marketValue":6077000000,"turnoverRate":0.1638,"status":0,"floatMarketCap":5667000000},"requestUrl":"/m/hq/s/300683","defaultTab":"news","newsList":[{"id":"2553222660","title":"A股创新药概念延续强势，亚宝药业涨停，键凯科技、汉商集团、悦康药业、哈三联、海特生物等涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222660","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553222660?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:35","pubTimestamp":1753320947,"startTime":"0","endTime":"0","summary":"A股 创新药 概念延续强势， 亚宝药业 涨停， 键凯科技 、 汉商集团 、 悦康药业 、 哈三联 、 海特生物 等涨幅居前。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724095832a6be9229&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724095832a6be9229&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0239","BK0229","300683","688658","BK0028","BK0077","BK0201","399300","159992","159982","600351","600774","BK0209","002900","688356"],"gpt_icon":0},{"id":"2553243529","title":"海特生物：7月22日高管严洁减持股份合计10.17万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2553243529","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553243529?lang=zh_cn&edition=full","pubTime":"2025-07-23 21:02","pubTimestamp":1753275779,"startTime":"0","endTime":"0","summary":"证券之星消息，根据7月23日市场公开信息、上市公司公告及交易所披露数据整理，海特生物（300683）最新董监高及相关人员股份变动情况：2025年7月22日公司董事严洁共减持公司股份10.17万股，占公司总股本为0.0777%。变动期间公司股价上涨7.65%，7月22日当日收盘报40.82元。海特生物近半年内的董监高及核心技术人员增减持详情如下：海特生物的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072300038493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2553990215","title":"7月23日海特生物（300683）龙虎榜数据：机构净买入1.09亿元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2553990215","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553990215?lang=zh_cn&edition=full","pubTime":"2025-07-23 17:21","pubTimestamp":1753262470,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年7月23日公布的交易公开信息显示，海特生物因连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年7月23日收盘，海特生物报收于43.75元，上涨7.18%，换手率18.9%，成交量23.07万手，成交额10.25亿元。从龙虎榜公布的三日买卖数据来看，机构合计净买入1.09亿元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072300029129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2553726005","title":"眼科医疗概念盘中拉升，海特生物涨18.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553726005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553726005?lang=zh_cn&edition=full","pubTime":"2025-07-23 10:16","pubTimestamp":1753237013,"startTime":"0","endTime":"0","summary":"07月23日，眼科医疗概念盘中拉升，截至10点16分，眼科医疗概念整体指数上涨1.03%，报1462.880点。从个股上来看，该概念的成分股中，海特生物涨18.40%，欧普康视、辰欣药业2只股涨幅超过5%。从资金上来看，截止发稿，眼科医疗概念主力净流入为3367.03万，其中爱尔眼科受到资金热捧，主力净流入6805.47万；拉长时间线来看，该板块近20日主力资金净流入-17.39亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072310165397b19433&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072310165397b19433&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603367","300683","BK0239"],"gpt_icon":0},{"id":"2553023827","title":"海特生物：截止7月18日公司股东人数为11,916户","url":"https://stock-news.laohu8.com/highlight/detail?id=2553023827","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553023827?lang=zh_cn&edition=full","pubTime":"2025-07-22 16:15","pubTimestamp":1753172120,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)07月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止7月20日收盘公司的股东人数是多少？谢谢海特生物回复：您好，感谢您对公司的关注。截止7月18日公司股东人数为11,916户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072200024376.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2553838352","title":"【生物制品板块震荡反弹，康辰药业涨停】生物制品板块震荡反弹，康辰药业涨停，百奥泰、赛升药业、海特生物、艾迪药业、赛分科技、君实生物等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2553838352","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553838352?lang=zh_cn&edition=full","pubTime":"2025-07-22 09:57","pubTimestamp":1753149421,"startTime":"0","endTime":"0","summary":"生物制品板块震荡反弹，康辰药业涨停，百奥泰、赛升药业、海特生物、艾迪药业、赛分科技、君实生物等跟涨。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/22095751870100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","BK0046","688177","300683","688180","BK0012","BK0229","BK0239","688758","603590","688488","01877","BK0028","BK1161","300485","BK1515","BK0262"],"gpt_icon":0},{"id":"2553447831","title":"7月21日海特生物（300683）龙虎榜数据：机构净买入4604.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553447831","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553447831?lang=zh_cn&edition=full","pubTime":"2025-07-21 17:41","pubTimestamp":1753090881,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年7月21日公布的交易公开信息显示，海特生物因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月21日收盘，海特生物报收于37.92元，上涨20.0%，涨停，换手率16.55%，成交量20.2万手，成交额7.27亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入4604.5万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072100024452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2553425077","title":"异动快报：海特生物（300683）7月21日14点9分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2553425077","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553425077?lang=zh_cn&edition=full","pubTime":"2025-07-21 14:10","pubTimestamp":1753078242,"startTime":"0","endTime":"0","summary":"证券之星7月21日盘中消息，14点9分海特生物触及涨停板。目前价格37.92，上涨20.0%。其所属行业医疗服务目前上涨。领涨股为海特生物。该股为肝炎概念，眼科，新冠病毒防治概念热股，当日肝炎概念概念上涨1.66%，眼科概念上涨1.44%，新冠病毒防治概念上涨1.22%。7月21日的资金流向数据方面，主力资金净流出847.29万元，占总成交额2.24%，游资资金净流入1193.98万元，占总成交额3.15%，散户资金净流出346.68万元，占总成交额0.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072100013801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2553447899","title":"CRO概念盘中拉升，海特生物涨12.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553447899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553447899?lang=zh_cn&edition=full","pubTime":"2025-07-21 09:36","pubTimestamp":1753061819,"startTime":"0","endTime":"0","summary":"07月21日，CRO概念盘中拉升，截至09点36分，CRO概念整体指数上涨0.61%，报534.190点。从个股上来看，该概念的成分股中，海特生物涨12.56%，南模生物、诚达药业、成都先导涨幅居前。从资金上来看，截止发稿，CRO概念主力净流入为1300.52万，其中亚太药业受到资金热捧，主力净流入5204.88万；拉长时间线来看，该板块近20日主力资金净流入-10.24亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072109365997adda8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072109365997adda8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688222","688265","BK0239","300683","BK0216"],"gpt_icon":0},{"id":"2552146305","title":"海特生物：截止7月10日公司股东人数为11,839户","url":"https://stock-news.laohu8.com/highlight/detail?id=2552146305","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552146305?lang=zh_cn&edition=full","pubTime":"2025-07-18 16:51","pubTimestamp":1752828671,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)07月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年7月10日，公司股东人数多少？海特生物回复：您好，感谢您对公司的关注。截止7月10日公司股东人数为11,839户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800026389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2550673689","title":"海特生物：天津汉康具有多个自主知识产权新药项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2550673689","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550673689?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:03","pubTimestamp":1752048191,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)07月09日在投资者关系平台上答复投资者关心的问题。投资者提问：公司CRO业务主要是国内的仿制药，创新药业务有单子吗？占比多少？海特生物回复：您好，感谢您对公司的关注。天津汉康是国内知名的CRO-CDMO一体化服务企业，致力于为行业提供一站式、系统化解决方案。目前具有多个自主知识产权的新药项目，覆盖抗肿瘤、心血管疾病、神经系统疾病等多个治疗领域。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070900024386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2548037075","title":"海特生物：子公司汉瑞药业可提供麦角硫因原料药","url":"https://stock-news.laohu8.com/highlight/detail?id=2548037075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548037075?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:06","pubTimestamp":1751357188,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：现在长寿药这么火，我看贵司子公司汉瑞药业官网有产品麦角硫因，是否属实？海特生物回复：您好，感谢您对公司的关注！汉瑞药业（荆门）有限公司坐落于湖北省荆门市化工循环产业园，拥有多个GMP多功能车间和商业化车间，反应釜体积30L~10000L，涵盖高、低温，氢化，可为客户提供包含2-硫代咪唑氨基酸（麦角硫因）在内的多种中间体和原料药。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100025057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2548075067","title":"海特生物：截止6月30日公司股东人数为11,408户","url":"https://stock-news.laohu8.com/highlight/detail?id=2548075067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548075067?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:06","pubTimestamp":1751357180,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年6月30日，公司股东人数多少？海特生物回复：您好，感谢您对公司的关注。截止6月30日公司股东人数为11,408户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100025035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2548075065","title":"海特生物：公司已完成部分股东股权收购并控股北京沙东","url":"https://stock-news.laohu8.com/highlight/detail?id=2548075065","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548075065?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:06","pubTimestamp":1751357174,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：北京沙东剩余股权购买回来需要多少钱？海特生物回复：您好。感谢您对公司的关注！公司目前已完成了部分股东的股权收购并控股北京沙东，公司会继续按照有关协议的约定履行相应的义务，相关协议已在招股说明书中进行了披露，请您查看公司的招股说明书。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100025025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2545440398","title":"海特生物：截止6月20日公司股东人数为11,157户","url":"https://stock-news.laohu8.com/highlight/detail?id=2545440398","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545440398?lang=zh_cn&edition=full","pubTime":"2025-06-24 15:30","pubTimestamp":1750750251,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年6月20日，公司股东人数多少？海特生物回复：您好，感谢您对公司的关注。截止6月20日公司股东人数为11,157户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062400019868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2544923268","title":"海特生物：截止6月10日公司股东人数为11,797户","url":"https://stock-news.laohu8.com/highlight/detail?id=2544923268","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544923268?lang=zh_cn&edition=full","pubTime":"2025-06-18 15:27","pubTimestamp":1750231631,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)06月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年6月10日，公司股东人数多少？海特生物回复：您好，感谢您对公司的关注。截止6月10日公司股东人数为11,797户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061800018176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2542304816","title":"海特生物收盘下跌2.37%，最新市净率1.47，总市值35.05亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542304816","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542304816?lang=zh_cn&edition=full","pubTime":"2025-06-11 17:08","pubTimestamp":1749632926,"startTime":"0","endTime":"0","summary":"6月11日，海特生物今日收盘26.78元，下跌2.37%，最新市净率1.47，总市值35.05亿元。股东方面，截至2025年5月30日，海特生物股东户数11355户，较上次增加520户，户均持股市值35.28万元，户均持股数量2.76万股。公司荣获“2023年度中国车谷招才引智优秀企业”称号、荣获“杰出中小投资者互动奖”。最新一期业绩显示，2025年一季报，公司实现营业收入1.57亿元，同比18.79%；净利润-13930370.19元，同比15.81%，销售毛利率44.38%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/11170851006620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2541897803","title":"每周股票复盘：海特生物（300683）股本股东变化，股东户数增加520户","url":"https://stock-news.laohu8.com/highlight/detail?id=2541897803","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541897803?lang=zh_cn&edition=full","pubTime":"2025-06-07 10:09","pubTimestamp":1749262150,"startTime":"0","endTime":"0","summary":"截至2025年6月6日收盘，海特生物报收于26.34元，较上周的25.26元上涨4.28%。本周，海特生物6月3日盘中最高价报29.18元。海特生物当前最新总市值34.48亿元，在医疗服务板块市值排名41/50，在两市A股市值排名3885/5148。本周关注点股本股东变化：截至2025年5月30日公司股东户数为1.14万户，较5月20日增加520户股本股东变化近日海特生物披露，截至2025年5月30日公司股东户数为1.14万户，较5月20日增加520.0户，增幅为4.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060700009911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300683","BK0239"],"gpt_icon":0},{"id":"2541831411","title":"海特生物（300683）新增【眼科】概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2541831411","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541831411?lang=zh_cn&edition=full","pubTime":"2025-06-06 16:25","pubTimestamp":1749198302,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，6月6日海特生物新增概念。海特生物主营业务：大分子生物药、小分子化学药、原料药与医药中间体的生产销售,同时也为国内外的制药企业提供制剂和原料药的CRO、CMO和CDMO技术服务。海特生物2025年一季报显示，公司主营收入1.57亿元，同比上升18.79%；归母净利润-1393.04万元，同比上升15.81%；扣非净利润-1707.92万元，同比上升24.55%；负债率15.03%，投资收益40.28万元，财务费用-117.55万元，毛利率44.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060600024195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0},{"id":"2540008639","title":"海特生物：截止5月30日公司股东人数为11,355户","url":"https://stock-news.laohu8.com/highlight/detail?id=2540008639","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540008639?lang=zh_cn&edition=full","pubTime":"2025-06-04 08:54","pubTimestamp":1748998451,"startTime":"0","endTime":"0","summary":"证券之星消息，海特生物(300683)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年5月31日，公司股东人数多少？海特生物回复：您好，感谢您对公司的关注。截止5月30日公司股东人数为11,355户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400004750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300683"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753549971689,"stockEarnings":[{"period":"1week","weight":0.4693},{"period":"1month","weight":0.841},{"period":"3month","weight":1.0914},{"period":"6month","weight":1.0962},{"period":"1year","weight":1.1834},{"period":"ytd","weight":0.9591}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0398},{"period":"3month","weight":0.0906},{"period":"6month","weight":0.1048},{"period":"1year","weight":0.2449},{"period":"ytd","weight":0.0722}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"武汉海特生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"11916人(较上一季度增加0.65%)","perCapita":"10243股","listingDate":"2017-08-08","address":"湖北省武汉市蔡甸区经济技术开发区海特科技园","registeredCapital":"13089万元","survey":"　　武汉海特生物制药股份有限公司的主营业务是大分子生物药、小分子化学药、原料药与医药中间体的生产销售，同时也为国内外的制药企业提供制剂和原料药的CRO、CMO和CDMO技术服务。公司的主要产品是技术服务、注射用鼠神经生长因子（金路捷）、注射用埃普奈明。公司荣获“2023年度中国车谷招才引智优秀企业”称号、荣获“杰出中小投资者互动奖”。","listedPrice":32.94},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海特生物(300683)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海特生物(300683)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海特生物,300683,海特生物股票,海特生物股票老虎,海特生物股票老虎国际,海特生物行情,海特生物股票行情,海特生物股价,海特生物股市,海特生物股票价格,海特生物股票交易,海特生物股票购买,海特生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海特生物(300683)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海特生物(300683)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}